Skip to main content

Possible Link Between Bisphosphonates, Esophageal Cancer Sparks FDA Review

The FDA once again is examining safety data related to the use of bisphosphonates. This time, the agency is reviewing conflicting reports regarding oral bisphosphonates and the risk for esophageal cancer.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino